COMP <GO>
HSIC vs UNH // REVENUE GROWTH (YOY)
Henry Schein Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: HSIC 3
— UNH 10
▲ REVENUE GROWTH (YOY) LEADER: HSIC
LAST: $86.62 (+2.05%) • MKT CAP: $9.65B
revenue-growth
4.00%
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
revenue-growth
3.33%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HSIC VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HSIC | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 31.10% | 88.31% | -57.21 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.20% | 12.38% | -1.18 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.5x | 15.3x | -5.77 | HSIC | /valuation <GO> |
| Free Cash Flow Yield | 1.23% | 6.25% | -5.02 | UNH | /fcf-yield <GO> |
| Operating Margin | 5.00% | 5.32% | -0.32 | UNH | /operating-margins <GO> |
| Net Profit Margin | 3.20% | 3.53% | -0.33 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 4.00% | 3.33% | +0.67 | HSIC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.81 | 3.09 | -0.28 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.1 | 55.1 | -1.00 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 0.33 | +0.56 | HSIC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.4x | 17.7x | +3.66 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.65B | $359.43B | -$349.78B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HSIC REV | UNH REV | HSIC GROSS % | UNH GROSS % | HSIC FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.18B | $447.57B | 31.1% | 88.7% | $118.7M | $16.07B |
| FY 2024 | $12.67B | $400.28B | 31.7% | 88.3% | $277.7M | $20.70B |
| FY 2023 | $12.34B | $371.62B | — | 89.6% | -$55.3M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HSIC // BETA 0.89
UNH // BETA 0.33